June 29, 2020 / 1:33 PM / 7 days ago

BRIEF-Avalon Reports Successful Completion Of Phase I Study Of Car T-Cell Therapy Candidate

June 29 (Reuters) - Avalon Globocare Corp:

* AVALON GLOBOCARE ANNOUNCES SUCCESSFUL COMPLETION OF PHASE I CLINICAL STUDY OF CAR T-CELL THERAPY CANDIDATE AVA-001

* AVALON GLOBOCARE CORP - TREATMENT WITH AVA-001 WAS GENERALLY WELL TOLERATED WITH MINIMAL TOXICITIES AND ADVERSE SIDE EFFECTS

* AVALON GLOBOCARE CORP - WILL PRESENT RESULTS OF THIS AVA-001 PHASE 1 CLINICAL TRIAL ON JULY 11,2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below